278 related articles for article (PubMed ID: 32851039)
1. Use of IFN-Based Biotherapeutics to Harness the Host Against Foot-And-Mouth Disease.
Medina GN; de Los Santos T; Diaz-San Segundo F
Front Vet Sci; 2020; 7():465. PubMed ID: 32851039
[TBL] [Abstract][Full Text] [Related]
2. Robust Protection against Highly Virulent Foot-and-Mouth Disease Virus in Swine by Combination Treatment with Recombinant Adenoviruses Expressing Porcine Alpha and Gamma Interferons and Multiple Small Interfering RNAs.
Kim SM; Park JH; Lee KN; Kim SK; You SH; Kim T; Tark D; Lee HS; Seo MG; Kim B
J Virol; 2015 Aug; 89(16):8267-79. PubMed ID: 26041279
[TBL] [Abstract][Full Text] [Related]
3. Use of Protein Pegylation to Prolong the Antiviral Effect of IFN Against FMDV.
Diaz-San Segundo F; Medina GN; Azzinaro P; Gutkoska J; Mogulothu A; Attreed SE; Lombardi KR; Shields J; Hudock TA; de Los Santos T
Front Microbiol; 2021; 12():668890. PubMed ID: 34025625
[TBL] [Abstract][Full Text] [Related]
4. Coinjection of a vaccine and anti-viral agents can provide fast-acting protection from foot-and-mouth disease.
You SH; Kim T; Choi JH; Park G; Lee KN; Kim B; Lee MH; Kim HS; Kim SM; Park JH
Antiviral Res; 2017 Jul; 143():195-204. PubMed ID: 28454913
[TBL] [Abstract][Full Text] [Related]
5. Constitutively Active IRF7/IRF3 Fusion Protein Completely Protects Swine against Foot-and-Mouth Disease.
Ramírez-Carvajal L; Diaz-San Segundo F; Ramirez-Medina E; Rodríguez LL; de Los Santos T
J Virol; 2016 Oct; 90(19):8809-21. PubMed ID: 27466421
[TBL] [Abstract][Full Text] [Related]
6. Preventive effects of quercetin against foot-and-mouth disease virus
Lee G; Kang HR; Kim A; Park JH; Lee MJ; Kim SM
Front Microbiol; 2023; 14():1121830. PubMed ID: 37250022
[TBL] [Abstract][Full Text] [Related]
7. Foot-and-mouth disease vaccines.
Diaz-San Segundo F; Medina GN; Stenfeldt C; Arzt J; de Los Santos T
Vet Microbiol; 2017 Jul; 206():102-112. PubMed ID: 28040311
[TBL] [Abstract][Full Text] [Related]
8. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
Grubman MJ
Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic treatment with PEGylated bovine IFNλ3 effectively bridges the gap in vaccine-induced immunity against FMD in cattle.
Attreed SE; Silva C; Rodriguez-Calzada M; Mogulothu A; Abbott S; Azzinaro P; Canning P; Skidmore L; Nelson J; Knudsen N; Medina GN; de Los Santos T; Díaz-San Segundo F
Front Microbiol; 2024; 15():1360397. PubMed ID: 38638908
[TBL] [Abstract][Full Text] [Related]
10. Duration of protection and humoral immunity induced by an adenovirus-vectored subunit vaccine for foot-and-mouth disease (FMD) in Holstein steers.
Sitt T; Kenney M; Barrera J; Pandya M; Eckstrom K; Warner M; Pacheco JM; LaRocco M; Palarea-Albaladejo J; Brake D; Rieder E; Arzt J; Barlow JW; Golde WT
Vaccine; 2019 Sep; 37(42):6221-6231. PubMed ID: 31493951
[TBL] [Abstract][Full Text] [Related]
11. A recombinant adenovirus bicistronically expressing porcine interferon-α and interferon-γ enhances antiviral effects against foot-and-mouth disease virus.
Kim SM; Kim SK; Park JH; Lee KN; Ko YJ; Lee HS; Seo MG; Shin YK; Kim B
Antiviral Res; 2014 Apr; 104():52-8. PubMed ID: 24485895
[TBL] [Abstract][Full Text] [Related]
12. Development of vaccines toward the global control and eradication of foot-and-mouth disease.
Rodriguez LL; Gay CG
Expert Rev Vaccines; 2011 Mar; 10(3):377-87. PubMed ID: 21434805
[TBL] [Abstract][Full Text] [Related]
13. The Foot-and-Mouth Disease Carrier State Divergence in Cattle.
Stenfeldt C; Eschbaumer M; Rekant SI; Pacheco JM; Smoliga GR; Hartwig EJ; Rodriguez LL; Arzt J
J Virol; 2016 Jul; 90(14):6344-64. PubMed ID: 27147736
[TBL] [Abstract][Full Text] [Related]
14. Antiviral activity of porcine interferon omega 7 against foot-and-mouth disease virus in vitro.
Li SF; Zhao FR; Gong MJ; Shao JJ; Xie YL; Chang HY; Zhang YG
J Med Virol; 2019 Feb; 91(2):208-214. PubMed ID: 30039874
[TBL] [Abstract][Full Text] [Related]
15. Foot-and-mouth disease virus non-structural protein 2B negatively regulates the RLR-mediated IFN-β induction.
Li M; Xin T; Gao X; Wu J; Wang X; Fang L; Sui X; Zhu H; Cui S; Guo X
Biochem Biophys Res Commun; 2018 Sep; 504(1):238-244. PubMed ID: 30177393
[TBL] [Abstract][Full Text] [Related]
16. Field-Deployable Reverse Transcription-Insulated Isothermal PCR (RT-iiPCR) Assay for Rapid and Sensitive Detection of Foot-and-Mouth Disease Virus.
Ambagala A; Fisher M; Goolia M; Nfon C; Furukawa-Stoffer T; Ortega Polo R; Lung O
Transbound Emerg Dis; 2017 Oct; 64(5):1610-1623. PubMed ID: 27589902
[TBL] [Abstract][Full Text] [Related]
17. Advances in Foot-and-Mouth Disease Virus Proteins Regulating Host Innate Immunity.
Peng J; Yi J; Yang W; Ren J; Wen Y; Zheng H; Li D
Front Microbiol; 2020; 11():2046. PubMed ID: 33162944
[TBL] [Abstract][Full Text] [Related]
18. Molecular Mechanisms of Immune Escape for Foot-and-Mouth Disease Virus.
Yang B; Zhang X; Zhang D; Hou J; Xu G; Sheng C; Choudhury SM; Zhu Z; Li D; Zhang K; Zheng H; Liu X
Pathogens; 2020 Sep; 9(9):. PubMed ID: 32899635
[TBL] [Abstract][Full Text] [Related]
19. In Vitro and in Vivo Antiviral Activity of Mizoribine Against Foot-And-Mouth Disease Virus.
Li SF; Gong MJ; Sun YF; Shao JJ; Zhang YG; Chang HY
Molecules; 2019 May; 24(9):. PubMed ID: 31058822
[TBL] [Abstract][Full Text] [Related]
20. Environmental Sampling as a Low-Technology Method for Surveillance of Foot-and-Mouth Disease Virus in an Area of Endemicity.
Colenutt C; Brown E; Nelson N; Wadsworth J; Maud J; Adhikari B; Chapagain Kafle S; Upadhyaya M; Kafle Pandey S; Paton DJ; Sumption K; Gubbins S
Appl Environ Microbiol; 2018 Aug; 84(16):. PubMed ID: 29959244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
